Reino Unido - inglês - MHRA (Medicines & Healthcare Products Regulatory Agency)

leo pharma - betamethasone valerate; fusidic acid - cutaneous cream - 1mg/1gram ; 20mg/1gram

Austrália - inglês - Department of Health (Therapeutic Goods Administration)

leo pharma pty ltd - calcipotriol, quantity: 50 microgram/g; betamethasone dipropionate (equivalent: betamethasone, qty 500 microgram/g) - gel - excipient ingredients: nitrogen; hydrogenated castor oil; polyoxypropylene-11 stearyl ether; butylated hydroxytoluene; liquid paraffin; dl-alpha-tocopherol - topical treatment of scalp psoriasis. topical treatment of mild to moderate plaque psoriasis on the body in adults.

Estados Unidos - inglês - NLM (National Library of Medicine)

leo pharma inc - tacrolimus (unii: wm0haq4wnm) (tacrolimus anhydrous - unii:y5l2157c4j) - tacrolimus anhydrous 0.3 mg in 1 g - protopic® ointment, both 0.03% and 0.1% for adults, and only 0.03% for children aged 2 to 15 years, is indicated as second-line therapy  for the short-term and non-continuous chronic treatment of moderate to severe atopic dermatitis in non-immunocompromised adults and children who have failed to respond adequately to other topical prescription treatments for atopic dermatitis, or when those treatments are not advisable. protopic® ointment is not indicated for children younger than 2 years of age (see boxed warning, warnings and precautions: pediatric use). protopic® ointment is contraindicated in patients with a history of hypersensitivity to tacrolimus or any other component of the ointment.

Austrália - inglês - Department of Health (Therapeutic Goods Administration)

leo pharma pty ltd - sodium fusidate, quantity: 250 mg - tablet, film coated - excipient ingredients: colloidal anhydrous silica; titanium dioxide; lactose monohydrate; crospovidone; hypromellose; microcrystalline cellulose; purified talc; magnesium stearate; dl-alpha-tocopherol - treatment of localised, as well as generalised, staphylococcal infections caused by susceptible organisms. in severe infections, deep-seated infections, infections due to methicillin-resistant staphylococci or when prolonged therapy may be required, fucidin must be given concurrently with other anti-staphylococcal antibiotic therapy.

Austrália - inglês - Department of Health (Therapeutic Goods Administration)

leo pharma pty ltd - calcipotriol -

Austrália - inglês - Department of Health (Therapeutic Goods Administration)

leo pharma pty ltd - sodium fusidate, quantity: 20 mg/g - ointment - excipient ingredients: white soft paraffin; cetyl alcohol; wool fat; liquid paraffin - skin lesions primarily and secondarily infected with staphylococci, e.g. abscesses, boils, furunculosis, impetigo, folliculitis, hidradenitis, pyoderma, sycosis barbae, otitis externa.

Nova Zelândia - inglês - Medsafe (Medicines Safety Authority)

leo pharma limited - diflucortolone valerate 0.1% - topical cream - 0.1 % - active: diflucortolone valerate 0.1% excipient: carbomer disodium edetate dihydrate liquid paraffin macrogol stearate 2000 methyl hydroxybenzoate propyl hydroxybenzoate purified water sodium hydroxide stearyl alcohol white soft paraffin - all skin diseases which respond to topical corticoid therapy (eg): contact dermatitis, contact eczema, occupational eczema vulgar, nummular, degenerative and seborrhoeic eczema, dyshidrotic eczema, eczema in varicose syndrome (but not directly onto lower limb ulcers), anal eczema, eczema in children, neurodermatitis (endogenous eczema, atopic dermatitis), psoriasis, lichen ruber planus et verrucosus, lupus erythematosus discoides, first degree burns, sunburn, insect bites.

Nova Zelândia - inglês - Medsafe (Medicines Safety Authority)

leo pharma limited - diflucortolone valerate 0.1% - topical ointment - 0.1 % - active: diflucortolone valerate 0.1% excipient: hydrogenated castor oil liquid paraffin microcrystalline wax white soft paraffin - all skin diseases which respond to topical corticoid therapy (eg): contact dermatitis, contact eczema, occupational eczema vulgar, nummular, degenerative and seborrhoeic eczema, dyshidrotic eczema, eczema in varicose syndrome (but not directly onto lower limb ulcers), anal eczema, eczema in children, neurodermatitis (endogenous eczema, atopic dermatitis), psoriasis, lichen ruber planus et verrucosus, lupus erythematosus discoides, first degree burns, sunburn, insect bites.

Reino Unido - inglês - MHRA (Medicines & Healthcare Products Regulatory Agency)

macleods pharma uk ltd - pyrazinamide - oral tablet - 500mg

Reino Unido - inglês - MHRA (Medicines & Healthcare Products Regulatory Agency)

macleods pharma uk ltd - propylthiouracil - oral tablet - 50mg